SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Mish's Global Economic Trend Analysis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: skinowski who wrote (100419)8/5/2009 6:21:11 PM
From: Elroy Jetson1 Recommendation  Read Replies (1) of 116555
 
Big Pharma has for decades increasingly become a stable of attorneys and salespeople who do not actually develop medications.

Big Pharma:

1.) negotiates licensing deals with the smaller pharma firms which actually develop drugs, such as Gilead or Amgen, then;

2.) finances large drug trials and use their legal expertise and well developed relationship with the FDA to gain approval;

3.) contracts out the production of the components of these drugs, and if necessary actually manufacture then;

4.) and most importantly use their sales force and attorneys generate sales to provide royalties for the small pharma firms who actually develop medications.
.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News